Company intelligence / Profile preview

RxCap

Lynnfield, Massachusetts, United Statesrxcap.com ↗

Ownership: Private
Development stage: Other

Overview

RxCap’s smart cap devices and software have demonstrated high rates of medication adherence in clinical studies. For example, a study on stroke survivors reported 90.9% effective prescription adherence using the platform. The system is easy to implement for both patients and research staff; data security is emphasized throughout their offerings. The company’s products are used by pharmacies, health plans, providers, device manufacturers—and have been validated in real-world clinical settings.

Therapeutic areas: PulmonologyNeurologyOther
Modalities: DeviceSoftwareData platform
Industry: Therapeutic Medical Devices

Partnerships

GerresheimerCentorOMRON Healthcare

Beyond the preview

Go deeper on RxCap.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RxCap.

Explore the full profile